Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1978 Jul;62(1):88–93. doi: 10.1172/JCI109118

Effect of Parathyroid Hormone and Uremia on Peripheral Nerve Calcium and Motor Nerve Conduction Velocity

David A Goldstein 1,2, Luis A Chui 1,2, Shaul G Massry 1,2
PMCID: PMC371740  PMID: 659642

Abstract

Peripheral neuropathy is not an uncommon complication of chronic uremia. Because parathyroid hormone, by raising brain calcium, is partly responsible for central nervous system aberrations in uremia, we studied the relative role of uremia, per se, and(or) parathyroid hormone on peripheral nerve calcium and motor nerve conduction velocity (MNCV). Studies were made in six groups of six dogs each, as follows: (a) normal dogs, (b) thyroparathyroidectomized (T-PTX) animals, (c) dogs with 3 days of uremia produced by bilateral nephrectomy, (d) T-PTX before the induction of acute renal failure, (e) normal dogs receiving 100 U/day of parathyroid extract (PTE) for 3 days, and (f) normal animals receiving 3 days of PTE followed by 5 days without PTE. Calcium content in peripheral nerve (expressed as milligram per kilogram of dry weight) was 252±5 (SE) in normal animals and 262±4 in T-PTX dogs. It was significantly (P < 0.01) higher in dogs with acute renal failure and intact parathyroid glands (410±12) and in normal animals receiving PTE (362±7). T-PTX, before acute renal failure, prevented the rise in peripheral nerve calcium (262±4) and PTE withdrawal was followed by the return of peripheral nerve calcium to normal (261±3). The increments in peripheral nerve calcium were associated with slowing of MNCV. It decreased significantly from 70±4 to 43±1 m/s after 3 days of acute uremia in dogs with intact parathyroid glands and T-PTX before acute renal failure prevented the fall in MNCV. Administration of PTE to normal animals reduced MNCV from 63±3 to 35±3 m/s and the withdrawal of PTE restored MNCV to normal (73±2 m/s). The results show that (a) excess parathyroid hormone increases peripheral nerve calcium and slows MNCV, (b) T-PTX, previously performed, prevents these changes in acute uremia, and (c) the withdrawal of PTE administration is followed by a reversal of the abnormalities.

Full text

PDF
88

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Arieff A. I., Massry S. G., Barrientos A., Kleeman C. R. Brain water and electrolyte metabolism in uremia: effects of slow and rapid hemodialysis. Kidney Int. 1973 Sep;4(3):177–187. doi: 10.1038/ki.1973.100. [DOI] [PubMed] [Google Scholar]
  2. Arieff A. I., Massry S. G. Calcium metabolism of brain in acute renal failure. Effects of uremia, hemodialysis, and parathyroid hormone. J Clin Invest. 1974 Feb;53(2):387–392. doi: 10.1172/JCI107571. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Baker P. F., Hodgkin A. L., Ridgway E. B. Depolarization and calcium entry in squid giant axons. J Physiol. 1971 Nov;218(3):709–755. doi: 10.1113/jphysiol.1971.sp009641. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bernstein D. S., Pletka P., Hattner R. S., Hampers C. L., Merrill J. P. Effect of total parathyroidectomy and uremia on the chemical composition of bone, skin and aorta in the rat. Isr J Med Sci. 1971 Mar;7(3):513–514. [PubMed] [Google Scholar]
  5. Berson S. A., Yalow R. S. Parathyroid hormone in plasma in adenomatous hyperparathyroidism, uremia, and bronchogenic carcinoma. Science. 1966 Nov 18;154(3751):907–909. doi: 10.1126/science.154.3751.907. [DOI] [PubMed] [Google Scholar]
  6. Bradbury M. W., Leeman C. R., Bagdoyanh, Berberian A. The calcium and magnesium content of skeletal muscle, brain, and cerebrospinal fluid as determined by atomic bsorption flame photometry. J Lab Clin Med. 1968 May;71(5):884–892. [PubMed] [Google Scholar]
  7. Dayan A. D., Gardner-Thorpe C., Down P. F., Gleadle R. I. Peripheral neuropathy in uremia. Pathological studies on peripheral nerves from 6 patients. Neurology. 1970 Jul;20(7):649–658. doi: 10.1212/wnl.20.7.649. [DOI] [PubMed] [Google Scholar]
  8. Guisado R., Arieff A. I., Massry S. G., Lazarowitz V., Kerian A. Changes in the electroencephalogram in acute uremia. Effects of parathyroid hormone and brain electrolytes. J Clin Invest. 1975 Apr;55(4):738–745. doi: 10.1172/JCI107984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Hollinrake K., Thomas P. K., Wills M. R., Baillod R. A. Observations on plasma magnesium levels in patients with uremic neuropathy under treatment by periodic hemodialysis. Neurology. 1970 Sep;20(9):939–942. doi: 10.1212/wnl.20.9.939. [DOI] [PubMed] [Google Scholar]
  10. Jebsen R. H., Tenckhoff H., Honet J. C. Natural history of uremic polyneuropathy and effects of dialysis. N Engl J Med. 1967 Aug 17;277(7):327–333. doi: 10.1056/NEJM196708172770702. [DOI] [PubMed] [Google Scholar]
  11. Nielsen V. K. The peripheral nerve function in chronic renal failure. VII. Longitudinal course during terminal renal failure and regular hemodialysis. Acta Med Scand. 1974 Mar;195(3):155–162. [PubMed] [Google Scholar]
  12. Parfitt A. M. Soft-tissue calcification in uremia. Arch Intern Med. 1969 Nov;124(5):544–556. [PubMed] [Google Scholar]
  13. Reiss E., Canterbury J. M. Genesis of hyperparathyroidism. Am J Med. 1971 May;50(5):679–685. doi: 10.1016/0002-9343(71)90123-9. [DOI] [PubMed] [Google Scholar]
  14. Schlaepfer W. W., Bunge R. P. Effects of calcium ion concentration on the degeneration of amputated axons in tissue culture. J Cell Biol. 1973 Nov;59(2 Pt 1):456–470. doi: 10.1083/jcb.59.2.456. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Tyler H. R. Neurologic disorders in renal failure. Am J Med. 1968 May;44(5):734–748. doi: 10.1016/0002-9343(68)90255-6. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES